FML Liquifilm en es it fr

FML Liquifilm Brand names, FML Liquifilm Analogs

FML Liquifilm Brand Names Mixture

  • L-S 100 Soluble Powder (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Sulfate))
  • Lincomycin Spectinomycin 100 Soluble Powder (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Hydrochloride))
  • Lincomycin Spectinomycin 4.4% G Premix (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Hydrochloride))

FML Liquifilm Chemical_Formula


FML Liquifilm RX_link

FML Liquifilm fda sheet

FML_Liquifilm FDA

FML Liquifilm msds (material safety sheet)

FML_Liquifilm MSDS

FML Liquifilm Synthesis Reference

No information avaliable

FML Liquifilm Molecular Weight

376.462 g/mol

FML Liquifilm Melting Point

297 oC

FML Liquifilm H2O Solubility

30 mg/L

FML Liquifilm State


FML Liquifilm LogP


FML Liquifilm Dosage Forms

Drops; Suspension

FML Liquifilm Indication

A topical anti-inflammatory product for ophthalmic use. For the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe

FML Liquifilm Pharmacology

No information avaliable

FML Liquifilm Absorption

No information avaliable

FML Liquifilm side effects and Toxicity

Side effects may include acute anterior uveitis and perforation of the globe. Keratitis, conjunctivitis, corneal ulcers, mydriasis, conjunctival hyperemia, loss of accommodation and ptosis have occasionally been reported following local use of corticosteroids. LD50 = 234 mg/kg (rats)

FML Liquifilm Patient Information

FML Liquifilm Organisms Affected

Humans and other mammals